Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158184 · ClinicalTrials.gov registry record · Phase 2
Prescription Opioid Effects in Abusers Versus Non-Abusers
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT00158184 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 27 participants.
The verdict
NCT00158184, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the abuse liability of oxycodone in individuals with, and without, a history of prescription opioid abuse.
Interventions
- DRUG oxycodone 15 mg
- DRUG oxycodone 30 mg
- DRUG Placebo 0 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2004-06 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158184
The ClinicalTrials.gov registry entry for NCT00158184 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which oxycodone 15 mg is the first listed.
NCT00158184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158184 about?
NCT00158184 is a clinical study titled "Prescription Opioid Effects in Abusers Versus Non-Abusers". The purpose of this study is to examine the abuse liability of oxycodone in individuals with, and without, a history of prescription opioid abuse.
What is the current status of trial NCT00158184?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2004-06. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00158184?
The interventions under investigation include: oxycodone 15 mg (DRUG), oxycodone 30 mg (DRUG), Placebo 0 mg (DRUG).
Who is sponsoring clinical trial NCT00158184?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.